AN EARLY CLINICAL PHASE-II EVALUATION OF PAROXETINE, A NEW POTENT AND SELECTIVE 5HT-UPTAKE INHIBITOR IN PATIENTS WITH DEPRESSIVE-ILLNESS

被引：35

作者：

BORUP, C

MEIDAHL, B

PETERSEN, IM

VANGTORP, A

HONORE, PL

机构：

[1] ST HANS MENTAL HOSP, DEPT F, DK-4000 ROSKILDE, DENMARK

[2] HOLBAEK CTY HOSP, DEPT PSYCHIAT, HOLBAEK, DENMARK

[3] BISPEBJERG HOSP, DEPT PSYCHIAT, DK-2400 COPENHAGEN NV, DENMARK

[4] AS FERROSAN, DIV RES, DK-2860 SOEBORG, DENMARK

来源：

PHARMACOPSYCHIATRIA | 1982年 / 15卷 / 06期

关键词：

D O I：

10.1055/s-2007-1019535

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：183 / 186

页数：4

共 13 条

[1]

[Anonymous], 1969, DIAGNOSIS DRUG TREAT

[2]

ASBERG M, 1976, SCIENCE, V191, P478

[3] REDUCTION OF WHOLE-BLOOD SEROTONIN IN DEPRESSED-PATIENTS TREATED WITH A NEW, SELECTIVE SEROTONIN-UPTAKE INHIBITOR, FEMOXETINE [J].

BORUP, C ;

PETERSEN, IM ;

LEFEVREHONORE, P ;

WETTERBERG, L .

PSYCHOPHARMACOLOGY, 1979, 63 (03) :241-243

[4] CENTRAL AND PERIPHERAL 5-HT UPTAKE IN RATS TREATED CHRONICALLY WITH FEMOXETINE, PAROXETINE, AND CHLORIMIPRAMINE [J].

BUUSLASSEN, J ;

LUND, J ;

SONDERGAARD, I .

PSYCHOPHARMACOLOGY, 1980, 68 (03) :229-233

[5] FACTORS INFLUENCING FREE SEROTONIN IN HUMAN PLASMA [J].

GENEFKE, IK ;

GAREL, A ;

MANDEL, P .

CLINICA CHIMICA ACTA, 1968, 20 (01) :61-&

[6] A RATING SCALE FOR DEPRESSION [J].

HAMILTON, M .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62

[7]

LAPIN IP, 1969, LANCET, V1, P132

[8]

LASSEN J B, 1978, European Journal of Pharmacology, V47, P351

[9] INFLUENCE OF NEW 5-HT-UPTAKE INHIBITOR PAROXETINE ON HYPERMOTILITY IN RATS PRODUCED BY PARA-CHLOROAMPHETAMINE (PCA) AND 4,ALPHA-DIMETHYL-META-TYRAMINE (H 77-77) [J].

LASSEN, JB .

PSYCHOPHARMACOLOGY, 1978, 57 (02) :151-153

[10]

LUND J, 1979, ACTA PHARMACOL TOX, V44, P289

← 1 2 →